SCHEMBL14033711

SCHEMBL14033711

CCOC(=O)c1cnn2c(Cl)c(Cc3ccccc3)c(C)nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.56
CDK2 P24941 1/20 0.56
ALDH1A1 P00352 9/20 0.55
APAF1 O14727 1/20 0.55
KDM4E B2RXH2 9/20 0.54
HSD17B10 Q99714 7/20 0.54
HPGD P15428 7/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
LMNA P02545 4/20 0.53
TP53 P04637 3/20 0.53
MAPT P10636 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
MAPK1 P28482 1/20 0.51
TSHR P16473 2/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
MEN1 O00255 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22796687 0.91 ALDH1A1 (0.56) CCNA2CDK2ALDH1A1APAF1KDM4E
SCHEMBL14033028 0.88 ALDH1A1 (0.56) CCNA2CDK2ALDH1A1APAF1KDM4E
SCHEMBL22796774 0.86 KDM4E (0.52) CCNA2CDK2ALDH1A1APAF1KDM4E
SCHEMBL22796777 0.85 ALDH1A1 (0.53) CCNA2CDK2ALDH1A1APAF1KDM4E
SCHEMBL8184450 0.83 KDM4E (0.49) CCNA2CDK2ALDH1A1KDM4EHSD17B10
SCHEMBL4936715 0.83 ALDH1A1 (0.67) CCNA2CDK2ALDH1A1KDM4EHSD17B10
SCHEMBL902729 0.82 ALDH1A1 (0.55) CCNA2CDK2ALDH1A1APAF1KDM4E
SCHEMBL5591509 0.81 SMN1; SMN2 (0.56) CCNA2CDK2ALDH1A1KDM4EHSD17B10
SCHEMBL22796688 0.81 HSD17B10 (0.67) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL15261996 0.81 ALDH1A1 (0.56) CCNA2CDK2ALDH1A1APAF1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 CCNA2 3734/4885CDK2 3435/4885ALDH1A1 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.